Search filters

List of works by Elena Almarza

Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells

scientific article

Brief report: reduced expression of CD18 leads to the in vivo expansion of hematopoietic stem cells in mouse bone marrow.

scientific article published in October 2014

Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy

scientific article published on 29 May 2007

Comparison of haematopoietic stem cell engraftment through the retro-orbital venous sinus and the lateral vein: alternative routes for bone marrow transplantation in mice

scientific article published on 13 January 2015

Correction of SCID-X1 using an enhancerless Vav promoter.

scientific article published on 7 February 2011

Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia

scientific article published in May 2010

Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy

scientific article published in February 2014

Optimization of lentiviral vectors for the gene therapy of fanconi anemia

article

PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes.

scientific article

Parallel multifunctionalization of nanoparticles: a one-step modular approach for in vivo imaging

scientific article

Preclinical gene therapy studies of fanconi anemia with lentiviral vectors

article

Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I

scientific article published in 2022

Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice

scientific article published in April 2004

The application of nanoparticles in gene therapy and magnetic resonance imaging.

scientific article published on 11 April 2011

The role of the vav promoter in gene therapy: Safer vectors with weaker and stable expression

article

Paulina is supported by:

About Paulina

Help